Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Treatment Of Infection-Associated Purpura Fulminans With Protein C Zymogen Is Associated With a High Survival Rate

Paul Knoebl, MD, Peter Schellongowski, MD, Thomas Staudinger, MD, Wolfgang R. Sperr, MD, Christian Scheibenpflug, MD

Blood (2013) 122 (21): 3606.

https://doi.org/10.1182/blood.V122.21.3606.3606

Published: 2013

Journal Articles

Eculizumab in Paroxysmal Nocturnal Hemoglobinuria (PNH): A Report of All 153 Patients Treated in the UK

Anita Hill, MBChB, PhD, Richard J Kelly, MBChB, Austin G Kulasekararaj, MBBS, MD, Shreyans A Gandhi, MBBS, MD, Lindsay D Mitchell, MBChB, Modupe Elebute, MBChB, MD, Stephen John Richards, PhD, Matthew Cullen, MSc, Louise M Arnold, RN, BSc, Joanna Large, RN, BSc, Alexandra Wood, RN, BSc, Gemma L Brooksbank, RN, BSc, Tracy Downing, Claire McKinley, BSc, Dena Cohen, BSc, MSc, Walter M Gregory, PhD, Judith C. W. Marsh, MD, PhD, Ghulam J. Mufti, MD, Peter Hillmen, MBChB, PhD

Blood (2012) 120 (21): 3472.

https://doi.org/10.1182/blood.V120.21.3472.3472

Published: 2012

Journal Articles

Long-Term Safety of Sustained Eculizumab Treatment in Patients with Paroxysmal Nocturnal Hemoglobinuria

Jeffrey Szer, MBBS, Petra Muus, MD, PhD, Alexander Roeth, MD, M.O Elebute, MD, FRCP, FRCPath, Antonio M. Risitano, MD, PhD, Hubert Schrezenmeier, MD, Jaroslaw P. Maciejewski, MD, PhD, Alvaro Urbano-Ispizua, MD, Carlos Manuel de Castro, III, MD, Gérard Socié, MD PhD, Robert A. Brodsky, MD

Blood (2012) 120 (21): 1260.

https://doi.org/10.1182/blood.V120.21.1260.1260

Published: 2012

Journal Articles

Long Term Safety and Efficacy of Sustained Eculizumab Treatment In Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Robert A Brodsky, MD, Carlos de Castro, III, MD, Hubert Schrezenmeier, MD, Professor, Antonio M. Risitano, MD, PhD, Joerg Schubert, MD, Jaroslaw P Maciejewski, MD, PhD, FACP, Ulrich Duehrsen, MD, Lucio Luzzatto, MD, FRCP, FRCPath, Petra Muus, MD, PhD, Jeffrey Szer, BMedSc, MBBS, FRACP, Gérard Socié, MD, PhD, Peter Hillmen, MBChB, FRCP, FRCPath, PhD

Blood (2010) 116 (21): 4237.

https://doi.org/10.1182/blood.V116.21.4237.4237

Published: 2010

Journal Articles

The Protein C Pathway in Human and Murine Sickle Cell Disease: Alterations in Protein C, Thrombomodulin (TM), and Endothelial Protein C Receptor (EPCR) at Baseline and during Acute Vaso-Occlusion

Yihe Guo, PhD, Teresa Uy, MD, Nancy Wandersee, PhD, J. Paul Scott, MD, Hartmut Weiler, PhD, Sandra Holzhauer, Dawn Retherford, Thomas Foster, Cheryl Hillery, MD

Blood (2008) 112 (11): 538.

https://doi.org/10.1182/blood.V112.11.538.538

Published: 2008

Journal Articles

Sustained Improvements in Transfusion Requirements, Fatigue and Thrombosis with Eculizumab Treatment in Paroxysmal Nocturnal Hemoglobinuria.

Gerard Socié, MD, PhD, Peter Hillmen, MB ChB, Petra Muus, MD, PhD, Jörg Schubert, MD, Ulrich Dührsen, DM, Antonio M. Risitano, MD PhD, Russell P. Rother, PhD, Robert A. Brodsky, MD, Jeffrey Szer, MB BS

Blood (2007) 110 (11): 3672.

https://doi.org/10.1182/blood.V110.11.3672.3672

Published: 2007

Journal Articles

Excessive Cardiotoxicity Despite Excellent Leukemia-Free Survival for Pediatric Patients with Down Syndrome (DS) and Acute Myeloid Leukemia (AML): Results from POG (Pediatric Oncology Group) Protocol 9421.

Maureen O’Brien, MD, Jeffrey Taub, MD, Kimo Stine, MD, Myron Chang, Yaddanapudi Ravindranath, MD, David Becton, MD, Gary Van Houten Dahl, MD

Blood (2006) 108 (11): 559.

https://doi.org/10.1182/blood.V108.11.559.559

Published: 2006

Journal Articles

Case of meningococcal sepsis and purpura fulminans

Blood (2005) 105 (1): 11.

https://doi.org/10.1182/blood.V105.1.11.11

Published: 2005

Journal Articles

Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis

Tom Sprong, Petter Brandtzaeg, Michael Fung, Anne M. Pharo, E. Arne Høiby, Terje E. Michaelsen, Audun Aase, Jos W. M. van der Meer, Marcel van Deuren, Tom E. Mollnes

Blood (2003) 102 (10): 3702–3710.

https://doi.org/10.1182/blood-2003-03-0703

Published: 2003

Journal Articles

An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans–associated meningococcemia

Barry White, Wendy Livingstone, Ciaran Murphy, Andrew Hodgson, Marie Rafferty, Owen P. Smith

Blood (2000) 96 (12): 3719–3724.

https://doi.org/10.1182/blood.V96.12.3719

Published: 2000

Journal Articles

Cellular origin and procoagulant properties of microparticles in meningococcal sepsis

Rienk Nieuwland, René J. Berckmans, Sarah McGregor, Anita N. Böing, Fred P. H. Th. M. Romijn, Rudi G. J. Westendorp, C. Erik Hack, Augueste Sturk

Blood (2000) 95 (3): 930–935.

https://doi.org/10.1182/blood.V95.3.930.003k46_930_935

Published: 2000

NARROW

Treatment Of Infection-Associated Purpura Fulminans With Protein C Zymogen Is Associated With a High Survival Rate

Eculizumab in Paroxysmal Nocturnal Hemoglobinuria (PNH): A Report of All 153 Patients Treated in the UK

Long-Term Safety of Sustained Eculizumab Treatment in Patients with Paroxysmal Nocturnal Hemoglobinuria

Long Term Safety and Efficacy of Sustained Eculizumab Treatment In Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

The Protein C Pathway in Human and Murine Sickle Cell Disease: Alterations in Protein C, Thrombomodulin (TM), and Endothelial Protein C Receptor (EPCR) at Baseline and during Acute Vaso-Occlusion

Sustained Improvements in Transfusion Requirements, Fatigue and Thrombosis with Eculizumab Treatment in Paroxysmal Nocturnal Hemoglobinuria.

Excessive Cardiotoxicity Despite Excellent Leukemia-Free Survival for Pediatric Patients with Down Syndrome (DS) and Acute Myeloid Leukemia (AML): Results from POG (Pediatric Oncology Group) Protocol 9421.

Case of meningococcal sepsis and purpura fulminans

Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis

An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans–associated meningococcemia

Cellular origin and procoagulant properties of microparticles in meningococcal sepsis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only